The effectiveness of the drug "Interleukin-1b" (gel form) in the treatment of periodontal disease in combination with gastric ulcer and duodenal ulcer
The study demonstrated that in the treatment of periodontal pathology in patients with gastric ulcer and duodenal ulcer drug application “Interleukin-1b” (gel form) affected the pathogenetic links, thereby restoring the structural and functional properties of the elements that make up the periodontium. Enhanced protective adaptive pathogenic mechanisms, correcting immune disorders in periodontal tissues has strengthened the terms of regeneration, depending on the location of the ulcer and rapid control of the course of inflammatory periodontal diseases.